NAVOS — History
CCN 504009 | 3-year financial timeline | COVID resilience: 48/100
🛡️ Public data only — no PHI permitted on this instance.
$39M
Latest Revenue (FY2022)
-7.2%
Revenue CAGR (3yr)
-13.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $46M | $39M | $39M | +0.1% | -7.2% |
| Operating Expenses | $54M | $51M | $44M | -12.7% | -9.2% |
| Operating Margin | -17.9% | -29.5% | -13.0% | +56.0% | +0.0% |
| Net Income | $-8M | $-12M | $-5M | +56.0% | +0.0% |
| Licensed Beds | 70 | 70 | 70 | +0.0% | +0.0% |
| Total Patient Days | 23,242 | 25,550 | 23,854 | -6.6% | +1.3% |
| Medicare Day % | 8% | 7% | 8% | +10.5% | -0.2% |
| Medicaid Day % | 53% | 57% | 61% | +6.6% | +6.7% |
COVID Impact & Recovery
Resilience Score: 48/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: -13.9% ($46M → $39M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-7.2%
This Hospital
+7.6%
State Avg
Latest Margin
-13.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $36M | -10.5% |
| FY2024 (proj) | $33M | -8.0% |
| FY2025 (proj) | $30M | -5.6% |